We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Potential Association Between Atrial Fibrillation and Dementia—Reply

Frank J. Wolters, MD1,2; Renée F. A. G. de Bruijn, MD, PhD1,2; M. Arfan Ikram, MD, PhD1,3
[+] Author Affiliations
1Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands
2Department of Neurology, Erasmus Medical Center, Rotterdam, the Netherlands
3Department of Radiology, Erasmus Medical Center, Rotterdam, the Netherlands
JAMA Neurol. 2016;73(5):607-608. doi:10.1001/jamaneurol.2015.5069.
Text Size: A A A
Published online


In Reply We thank Chen and colleagues for their interest in our work1 and are pleased that our report triggers debate about the optimal treatment of atrial fibrillation (AF) to prevent dementia, in addition to stroke and other thromboembolic complications of AF.

The main concerns that Chen et al express in their letter relate to uncertainty about the type of anticoagulant treatment and treatment adverse effects in our study. The first large phase 3 trials that compared novel oral anticoagulants with warfarin for thromboprophylaxis in AF appeared in late 2009 (RE-LY for dabigatran) and in 2011 (ARISTOTLE for apixaban and ROCKET-AF for rivaroxaban). As follow-up in our study lasted until February 2010, essentially all patients treated with anticoagulants in our study were prescribed coumarin derivatives, rather than novel oral anticoagulants. Consequently, differences in types of anticoagulants are unlikely to have influenced our findings. Despite proven efficacy of preventive treatment in younger as well as elderly patients,2 AF remains largely undertreated for the prevention of stroke.3,4 Of all patients diagnosed as having AF during follow-up in our study, 57.9% started anticoagulant treatment during the course of the study. We did not specifically assess for adverse effects. However, as we observed associations of exposure time both in users and in nonusers of anticoagulants, these do not appear explicable by bias due to treatment adverse effects.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





May 1, 2016
Chan Chen, MD, PhD; Jin Liu, MD, PhD; Tao Zhu, MD, PhD
1Department of Anesthesiology and Translational Neuroscience Center, West China Hospital, Sichuan University, Sichuan, China.
JAMA Neurol. 2016;73(5):607. doi:10.1001/jamaneurol.2015.5066.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...